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Persistent organic pollutants (POPs) are chemi-
cal substances that persist in the environment, 
bioaccumulate through the food web, and 
pose a risk of causing adverse effects to human 
health and the environment. There is evidence 
of long-range transport of these substances to 
regions where they have never been used or 
produced, resulting in exposure of most human 
populations to POPs through consumption of 
fat-containing food such as fish, dairy products, 
and meat (Letcher et al. 2010).
During recent years, elevated circulating 
levels of POPs have been associated with a 
number of cardiovascular (CV) risk factors, 
such as hypertension, obesity, and diabetes, as 
well as with metabolic syndrome (Everett et al. 
2008; Ha et al. 2009; Lee et al. 2007, 2011b; 
Rönn et al. 2011; Uemura et al. 2009). 
Furthermore, circulating levels of POPs have 
been associated with a history of myocardial 
infarction (Flesch-Janys et al. 1995; Sergeev 
and Carpenter 2005).
A characteristic feature of myocardial 
infarction is atherosclerosis. Because coronary 
and carotid artery atherosclerosis often go hand 
in hand (Hulthe et al. 1997), we hypothesized 
that participants with high levels of circulating 
POPs would have a higher incidence of carotid 
atherosclerotic plaques. Furthermore, because 
we recently found that the echogenicity of the 
intima-media complex in the carotid artery, 
a possible marker of lipid infiltration in the 
vascular wall, is a predictor of future CV death 
(Wohlin et al. 2009), we also investigated 
whether POP levels are associated with the 
gray scale median of the carotid artery intima-
media complex (IM-GSM). To test these 
hypotheses, we used the population-based 
Prospective Investigation of the Vasculature 
in Uppsala Seniors (PIVUS) study (Lind et al. 
2005), from which we have data on athero-
sclerosis and circulating POP levels for almost 
1,000 participants.
Specifically, we tested associations between 
POP levels and the prevalence of overt carotid 
plaques, and intima-media thickness (IMT; 
an early marker of atherosclerosis develop-
ment measurable in participants without 
overt plaque). In addition, we tested associa-
tions with carotid artery IM-GSM, a marker 
of lipid infiltration in the vascular wall that 
might be altered even before a plaque could 
be measured.
Materials and Methods
Participants. Eligible participants were all 70 
years of age and lived in the community of 
Uppsala, Sweden. The participants were ran-
domly chosen from the register of persons 
living in the community. A total of 1,016 
persons participated, giving a participation 
rate of 50.1%. The study was approved by 
the Ethics Committee of the University of 
Uppsala, and all the participants gave their 
informed consent before the study.
All participants were evaluated in the 
morning after an overnight fast. No medica-
tion or smoking was allowed after midnight. 
The participants were asked to answer a ques-
tionnaire about their medical history, smoking 
habits, and current use of regular medication.
We measured the blood pressure in the 
noncannulated arm of each participant using 
a calibrated mercury sphygmomanometer. 
Blood pressure was measured to the nearest 
1 mmHg after at least 30 min of rest, and the 
average of three recordings was used. Lipid 
variables and fasting blood glucose were meas-
ured by standard laboratory techniques.
Ultrasound evaluation of the carotid 
artery. The carotid artery was assessed by 
external B-mode ultrasound imaging (Acuson 
XP128 with a 10 MHz linear transducer; 
Acuson Corp, Mountain View, CA, USA). 
We visually inspected the common carotid 
artery, the bulb, and the internal carotid artery 
at both sides for the presence of plaque. A 
plaque was judged to be present in a particular 
carotid artery if a local thickening of the IMT 
was seen that was > 50% thicker than the 
surrounding IMT in any part of the carotid 
artery investigated. We recorded the presence 
of carotid plaques in none, one, or both of the 
carotid arteries (Figure 1).
The images were digitized and imported 
into the automated Artery Measurement 
Software, version 1.0 (Liang et al. 2000) for 
dedicated anal  ysis of IMT and the IM-GSM. 
For IMT analysis, a maximal 10-mm seg-
ment with good image quality was chosen 
from the common carotid artery close to the 
bifurcation point. A region of interest was 
placed manually around the intima-media 
complex, which was evaluated for IMT. The 
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Ba c k g r o u n d a n d o B j e c t i v e: Increased circulating levels of persistent organic pollutants (POPs) 
have been associated with myocardial infarction. Because myocardial infarction is an atherosclerotic 
disease, we investigated, in a cross-sectional study, whether POP levels are related to atherosclerosis.
Me t h o d s : In the population-based Prospective Investigation of the Vasculature in Uppsala Seniors 
(PIVUS) study (n = 1,016 participants 70 years of age), the prevalence of carotid artery plaques was 
determined by ultrasound. The number of carotid arteries with plaques (0, 1, or 2) was recorded. 
Also, the intima-media thickness (IMT) and gray scale median of the intima-media complex 
(IM-GSM) were measured. Twenty-three POPs, comprising 16 polychlorinated biphenyls (PCBs), 
5 pesticides, 1 dioxin, and 1 brominated compound (brominated diphenyl ether congener BDE-47), 
were analyzed by high-resolution chromatography coupled to high-resolution mass spectrometry.
re s u l t s: Seven of the POPs (PCB congeners 153, 156, 157, 170, 180, 206, and 209) were signifi-
cantly associated with the number of carotid arteries with plaques even after adjusting for multiple 
risk factors (sex, waist circumference, body mass index, fasting blood glucose, systolic and diastolic 
blood pressure, high-density lipoprotein and low-density lipoprotein cholesterol, serum triglycer-
ides, smoking, antihypertensive treatment, and statin use; p = 0.002–0.0001). Highly chlorinated 
PCBs (congeners 194, 206, and 209) were associated with an echolucent IM-GSM (p < 0.0001 after 
adjustment), whereas associations between POPs and IMT were modest.
co n c l u s i o n s: Circulating levels of PCBs were associated with atherosclerotic plaques and echo-
genicity of the intima-media complex independent of cardiovascular risk factors, including lipids. 
This suggests that POPs may be a risk factor for myocardial infarction, but associations need to be 
confirmed in prospective studies.
key w o r d s : atherosclerosis, atherosclerotic plaques, persistent organic pollutants (POPs), pesti-
cides. Environ Health Perspect 120:38–43 (2012).  http://dx.doi.org/10.1289/ehp.1103563 [Online 
11 October 2011]POPs and carotid atherosclerosis
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program calculated the echogenicity in the 
intima-media complex by analyzing individ-
ual pixels within the region of interest on a 
scale from 0 (black) to 256 (white). Thus, 
a low IM-GSM value indicated a lipid-rich 
wall, while a high value represented a vascular 
wall rich in collagen or calcium. Like IMT, 
the gray scale median value given is the mean 
value from right and left carotid arteries. We 
repeated the IMT measurements in 30 ran-
dom participants, giving a coefficient of varia-
tion for carotid artery IMT of 7.2% and for 
IM-GSM of 7.5%.
Method for analyses of POPs. POPs were 
measured in stored serum samples collected 
at baseline. We used a sample cleanup and 
extraction method based on a method by 
Sandau et al. (2003), with some modifica-
tions. Briefly, 1 mL formic acid was added to 
0.5 mL plasma sample and sonicated. Labeled 
13C internal standards and 1 mL 3% iso-
propanol in water were added after 60 min, 
followed by another sonication. Solid-phase 
extraction (SPE) was performed by loading 
the sample on a conditioned Oasis® HLB 
SPE (Waters, Milford, MA, USA) cartridge 
(6 cm3/150 mg). The cartridge was rinsed 
with 6 mL 3% isopropanol in water and 
6 mL 40% methanol in water. After drying 
under nitrogen, the target compounds were 
eluted with 6 mL methylene chloride:hexane 
(1:1). Further cleanup was performed using 
a small, activated multilayer silica gel column 
(2 mL, 1.5 g) eluted with 7.5 mL hexane. 
After evaporation and addition of the 13C-
labeled recovery standard, the volume was 
reduced to 25 μL tetradecane. The final meas-
urements were performed on a Micromass 
Autospec Ultima (Waters) high-resolution gas 
chromatograph/high-  resolution mass spec-
trometer. We monitored the two most abun-
dant ions of the chlorine or bromine cluster 
in addition to one ion for the 13C-labeled 
internal and recovery standards by injecting 
2 μL on a 6890N gas chromatograph (Agilent 
Technologies, Atlanta, GA, USA) contain-
ing a 30 m × 0.25 i.d. × 0.25 μm DB-5 
capillary column (SGE Analytical Science, 
Victoria, AUS).
Quality assurance/quality control. Quality 
control plasma samples and procedural blank 
samples were incorporated in each batch of 
10 samples. Blank samples did not contain 
any target compounds at levels > 5% of the 
levels in the samples except for cis-chlordane 
and trans-chlordane. The recoveries of the 
internal standards were satisfactory, in general 
ranging from 60–110%. The relative stand-
ard deviation of the 100 quality assurance/
quality control (QA/QC) samples was < 25% 
for all compounds except for the compounds 
that were present at low levels and just above 
the limit of detection (LOD) in the QA/QC 
sample. The laboratory routinely takes part in 
international laboratory comparison studies, 
with good results (z-scores < 2).
Tables 1 and 2 provide a detailed descrip-
tion of the POPs with detection rates, LODs, 
and distribution.
A total toxic equivalency (TEQ) value was 
calculated for the polychlorinated biphenyls 
(PCBs) as well as octachlorodibenzo-p-dioxin 
(OCDD) according to Van den Berg et al. 
(1998). TEQ was also calculated separately 
for the dioxin-like non-ortho-PCBs (conge-
ners 126 and 169) and the dioxin-like mono-
ortho-PCBs.
Statistical analysis. POPs were measured 
in 992 participants; data were missing for 
some participants because of a lack of plasma 
samples. IMT and IM-GSM were evaluated in 
990 participants, while plaque prevalence was 
evaluated in only 943 participants because of 
bad image quality for some participants. Data 
for individual model covariates used to adjust 
for potential confounding were missing for 
< 10 participants.
We evaluated all variables for non  normality. 
Variables with a skewed distribution, including 
fasting glucose, serum triglycerides, all POPs, 
the sum of the PCBs, and TEQ, were natural 
log (ln) transformed. In addition, the POPs 
were divided into quintiles to evaluate potential 
non  linear relationships.
Ordinal logistic regression models were 
used when the outcome was number of carotid 
arteries with plaques (grouped as 0, 1, or 2; the 
dependent variable). Linear regression was used 
when the outcomes were the continuous vari-
ables IMT or IM-GSM (the dependent vari-
able). Linear and logistic regression modeling 
was done according to Dobson (2002).
We evaluated all interactions between the 
POP levels and sex for all POPs and for all 
outcomes by introducing an interaction term 
between the POP under investigation and sex 
together with the POP and sex terms. Because 
no such interactions (p < 0.05) were found, 
sex adjustment was performed in the first set 
of models.
In the second sets of models, we adjusted 
for multiple CV risk factors [sex, waist 
  circumference, body mass index (BMI), 
ln-transformed fasting blood glucose, systolic 
blood pressure (SBP), diastolic blood pressure 
(DBP), high-density lipoprotein (HDL) and 
low-density lipoprotein (LDL) cholesterol, 
ln-transformed serum triglycerides, current 
smoking, antihypertensive treatment, and 
statin use].
In all the above models, analyses were first 
run with the POPs modeled as ln-transformed 
continuous variables and categorized using 
quintiles. Because of the large number of POPs 
analyzed, we applied a Bonferroni correction 
to determine the alpha level for statistical sig-
nificance (0.05/21 = 0.00238) for each of the 
three outcomes: plaque occurrence, IMT, and 
IM-GSM. The software used was STATA (ver-
sion 11; StataCorp, College Station, TX, USA).
Figure 1. An ultrasonographic image of the left carotid artery from a study participant. The blood inside the 
artery appears black. The right side of the image shows the part of the common carotid artery where IMT 
and IM-GSM are measured (rectangle). IMT is the thickness of that part of the vascular wall, and IM-GSM 
is a measure of the echogenicity (gray scale) of the same part of the wall. At the left side of the image, the 
carotid artery has divided into an internal part and an external part. In the bifurcation region, two plaques 
are outlined.Lind et al.
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Approximately 7% of the cohort reported a his-
tory of myocardial infarction, 4% stroke, and 
9% diabetes mellitus. Almost half the cohort 
(45%) reported use of CV medication, with 
antihypertensive medication being the most 
common (32%). Fifteen percent of the par-
ticipants reported use of statins. Two percent 
of the sample were on insulin therapy, and 
6% were on regular oral antiglycemic drugs 
(Table 1; for details, see Lind et al. 2005).
A total of 23 POPs were measured: 16 PCB 
congeners, 5 organochlorine (OC) pesticides, 
1 OCDD, and 1 brominated diphenyl ether 
(BDE) congener. We evaluated POPs that we 
found at detectable levels in > 90% of the study 
population. Because the statistical analysis is lim-
ited by a large number of cases with undetect-
able levels, two OC pesticides (trans-chlordane 
and cis-chlordane) with detection rates < 10% 
were excluded from the final analyses (Table 2).
POPs versus carotid plaques. Models of 
ln-transformed POP levels as continuous vari-
ables identified 7 POPs (PCB congeners 153, 
156, 157, 170, 180, 206, and 209) that were 
significantly associated (p < 0.00238) with the 
number of carotid arteries with plaques, even 
after adjusting for sex or sex and multiple CV 
risk factors (Table 3).
No significant interactions were seen 
between POP levels and sex regarding carotid 
plaque except for hexachlorobenzene (HCB). 
For HCB, however, no statistically significant 
relationships with carotid atherosclerosis were 
seen after adjusting for multiple testing [after 
adjusting for multiple risk factors; men: odds 
ratio (OR) = 0.92; 95% confidence interval 
(CI): 0.60, 1.41; women: OR = 1.5; 95% CI: 
1.01, 2.24]. For the other POPs, we adjusted, 
rather than stratified, the sample for sex.
When we divided the POP levels into 
quintiles, we found monotonic relationships 
versus the number of arteries with plaques for 
the POPs described above (data not shown).
A significant relationship was found 
between the ln-transformed sum of the PCBs 
and the number of arteries with plaques after 
adjusting for multiple risk factors (OR = 1.03; 
95% CI: 1.01, 1.05; p = 0.002). When we 
summed subsets of PCBs according to the 
number of chlorine atoms, PCBs with fewer 
than six chlorine atoms were not related to 
carotid plaques, whereas those with six or 
more chlorine atoms were significantly associ-
ated with plaque prevalence (Table 3).
Total TEQ (ln-transformed) was not sig-
nificantly associated with the number of arter-
ies with plaques. Nonetheless, TEQ for the 
dioxin-like mono-ortho-PCBs, but not for the 
dioxin-like non-ortho-PCBs, was significantly 
related to plaque prevalence (Table 3).
POPs versus IMT. No single POP was 
related to IMT after adjusting for multiple 
risk factors and multiple testing (Table 3). 
No evidence was seen of any low-dose effect, 
as defined by a marked change in the median 
for IMT already taking place at the second 
quartile (data not shown).
The sum of the PCBs was not significantly 
associated with IMT after adjusting for mul-
tiple risk factors. The sum of PCBs with fewer 
than 8 chlorine atoms also was not associated 
with IMT, but the sum of PCBs with 8–10 
chlorine atoms was significantly related to 
IMT (p = 0.009; Table 3). Total TEQ was 
associated with IMT after adjusting for mul-
tiple risk factors (p = 0.009; Table 3). The 
TEQ for the dioxin-like non-ortho-PCBs, but 
not for the dioxin-like mono-ortho-PCBs, was 
also significantly associated with IMT.
Table 1. Selected basic characteristics and major CV risk factors in the PIVUS study (n = 1,016; 50.2% 
females).
Variable Mean ± SD or n (%) Median (range)
Height (cm) 169 ± 9.1 169 (151–190)
Weight (kg) 77 ± 14  76 (49–116)
Waist circumference (cm) 91 ± 12 90 (67–123)
BMI (kg/m2) 27.0 ± 4.3 26.6 (19.1–39)
Waist:hip ratio 0.90 ± 0.075 0.90 (0.73–1.08)
SBP (mmHg) 150 ± 23 148 (105–210)
DBP (mmHg) 79 ± 10 78 (56–105)
Serum cholesterol (mmol/L) 5.4 ± 1.0 5.4 (3.2–7.8)
LDL cholesterol (mmol/L) 3.3 ± 0.88 3.3 (1.4–5.6)
HDL cholesterol (mmol/L) 1.5 ± 0.42 1.4 (0.8–2.9)
Serum triglycerides (mmol/L) 1.3 ± 0.60 1.15 (0.46–3.6)
Fasting blood glucose (mmol/L) 5.3 ± 1.6 5 (3.8–13.5)
IMT 0.88 ± 0.16 0.87 (0.58–1.35)
IM-GSM 78.8 ± 23.8 75.5 (37–143.5)
Current smoking 107 (11) —
History of myocardial infarction 72 (7) —
History of stroke 37 (4) —
History of diabetes mellitus 88 (9) —
Any CV medication 461 (45) —
Antihypertensive medication 317 (31) —
Statin treatment 149 (15) —
Insulin therapy 18 (2) —
Oral antiglycemic drug therapy 62 (6) —
No carotid artery plaque 327 (35) —
Unilateral carotid plaque 343 (36) —
Bilateral carotid plaque 273 (29) —
Table 2. Serum concentrations (pg/mL) of POPs in the PIVUS study (n = 1,016; 50.2% females).
POP
Detection 
rate (%) LOD
POP concentration 
[median (25th–75th 
percentile)]
PCBs
PCB-74 (2,2´,4,4´,5-pentachlorobiphenyl) 100 8.5 91.4 (63.9–128.1)
PCB-99 (2,2´,4,4´,5-pentachlorobiphenyl) 99.5 10.0 90.9 (62.4–131.9)
PCB-105 (2,3,3´,4,4´-pentachlorobiphenyl)a 100 5.9 32.0 (21.0–46.8)
PCB-118 (2,3´,4,4´,5-pentachlorobiphenyl)a 100 25.3 200.6 (136.4–281.0)
PCB-126 (3,3´,4,4´,5-pentachlorobiphenyl)b 95.6 8.0 40.4 (71.9–385.8)
PCB-138 (2,2´,3,4,4´,5´-hexachlorobiphenyl) 99.6 108.7 819.3 (619.2–1115.8)
PCB-153 (2,2´,4,4´,5,5´-hexachlorobiphenyl) 100 117.7 1427.6 (1114.4–1847.9)
PCB-156 (2,3,3´,4,4´,5-hexachlorobiphenyl)a 100 10.8 154.3 (118.7–197.6)
PCB-157 (2,3,3´,4,4´,5´-hexachlorobiphenyl)a 100 1.5 28.0 (21.4–37.0)
PCB-169 (3,3´,4,4´,5,5´-hexachlorobiphenyl)b 99.7 17.5 171.4 (130.1.9–636.4)
PCB-170 (2,2´,3,4,4´,5,5´-heptachlorobiphenyl) 100 38.9 497.5 (385.7–633)
PCB-180 (3,3´,4,4´,5,5´-hexachlorobiphenyl) 100 65.3 1165.4 (917.8–1487.8)
PCB-189 (2,3,3´,4,4´,5,5´-heptachlorobiphenyl)a 100 1.7 19.3 (14.6–25.8)
PCB-194 (2,2´,3,3´,4,4´,5,5´-octachlorobiphenyl) 98.6 4.2 119.4 (87.6–158.9)
PCB-206 (2,2´,3,3´,4,4´,5,5´,6-nonachlorobiphenyl) 100 0.8 26.8 (20.8–35.2)
PCB-209 (2,2´,3,3´,4,4´,5,5´,6,6´-decachlorobiphenyl) 100 1.2 26.2 (19.6–34.7)
OCDD  80.6 1.4 2.6 (1.4–4.2)
OC pesticides
HCB 98.6 89.1 253.6 (189.1–336.5)
cis-Chlordane 9.6 —  < LOD
trans-Chlordane 3.4 —  < LOD
trans-Nonachlordane (TNC) 100 5.9 139.6 (91.6–211.4)
DDE 100 11.5 1859.8 (1024.0–3472.1)
BDE-47 (2,2´,4,4´-tetra-bromodiphenyl ether) 77.2 9.2 12.6 (9.0–19.5)
aDioxin-like PCB (mono-ortho substituted). bDioxin-like PCB (coplanar, non-ortho substituted).POPs and carotid atherosclerosis
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 1 | January 2012  41
POPs versus IM-GSM. IM-GSM was 
inversely associated with ln-transformed 
PCB-126 and the highly chlorinated PCBs 
(congeners 194, 206, and 209) after adjust-
ing for multiple risk factors (p < 0.0001; 
Table 3) and positively associated with HCB 
and trans-nonachlordane (TNC; p < 0.0001). 
The inverse relationship between 1,1-bis-(4-
chlorophenyl)-2,2-dichloroethene (DDE) 
levels and IM-GSM approached significance 
after adjusting for multiple risk factors and 
multiple testing (p = 0.003).
No significant interactions were seen 
between the POP levels and sex regarding 
IM-GSM. Consequently, we adjusted, rather 
than stratified, the sample for sex. When 
the POP levels were divided into quintiles, 
monotonic relationships were seen between 
IM-GSM and PCBs congeners 206 and 209 
(data not shown).
An inverse significant relationship was 
found between the sum of the PCBs and 
IM-GSM after adjusting for multiple risk fac-
tors (p = 0.002; Table 3). When the sum of 
PCBs was divided according to the number of 
chlorine atoms, PCBs with fewer than 8 chlo-
rine atoms were not associated with IM-GSM; 
however, PCBs with 8–10 chlorine atoms had 
a significant inverse association with IM-GSM 
(p = 0.0001). Total TEQ was inversely related 
to IM-GSM after adjusting for multiple risk 
factors (p = 0.0001). However, only TEQ for 
the dioxin-like non-ortho-PCBs, not for the 
dioxin-like mono-ortho-PCBs, was signifi-
cantly related to IM-GSM.
Stratification by CV medication. To 
investigate whether the observed associations 
reported above were similar in participants 
with CV medication and those without, we 
performed the analysis again in participants 
with CV medication (45% of the sample) 
and participants without CV medication 
separately. In general, estimated associations 
according to medication use were comparable 
for all three outcomes with those estimated 
for the population as a whole. One excep-
tion was the association between OCDD and 
IM-GSM, which was evident only in partici-
pants not using CV medication (OR = 1.51; 
95% CI: 1.41, 2.01; vs. participants using CV 
medication: OR = 1.00; 95% CI: 0.74, 1.37).
Discussion
In the present cross-sectional study, several 
of the individual PCBs, as well as the sum of 
the PCBs, were associated with the presence 
of carotid artery plaques. Some of the highly 
chlorinated PCBs were also associated with 
the echogenicity of the intima-media com-
plex, a marker of vascular wall composition. 
Total TEQ was positively associated with 
IMT and inversely associated with the echo-
genicity of the intima-media complex but 
not associated with plaque prevalence. These 
relationships were statistically significant after 
adjusting for CV risk factors, including lipids, 
suggesting that POPs may have a vascular 
effect not mediated by traditional risk factors 
for atherosclerosis. To the best of our knowl-
edge, no other study has reported associations 
between POP levels and measures of athero-
sclerosis in a large human sample.
Comparison  with  the  literature. 
Associations between POP exposure and myo-
cardial infarction based on studies of highly 
exposed individuals (through accident or occu-
pational exposure) and studies of representative 
population-based samples have been reported 
(Chase et al. 1982; Dalton et al. 2001; Sergeev 
and Carpenter 2010). However, because POP 
exposure has also been associated with well-
known CV risk factors such as hypertension, 
diabetes, hyperlipidemia, and obesity (Everett 
et al. 2008; Goncharov et al. 2008; Lee et al. 
Table 3. Relationships among POPs, plaques in the carotid artery, and echogenicity IM-GSM in the common carotid artery (ln-transformed continuous 
  variables). 
Carotid plaques IM-GSM IMT
POP OR (95% CI)
Multiple adjusted 
p-valuea
Regression coefficient 
(95% CI)
Multiple adjusted 
p-valuea
Regression coefficient 
(95% CI)
Multiple adjusted 
p-valuea
PCB-74 1.28 (1.00, 1.63) 0.054 2.3 (–0.71, 5.29) 0.14 0.15 (–0.005, 0.035) 0.17
PCB-99 1.29 (1.04, 1.61) 0.02 0.41 (–2.19, 3.01) 0.76 0.001 (–0.016, 0.019) 0.87
PCB-105b 1.07 (0.86, 1.33) 0.53 0.77 (–1.88, 3.43) 0.57 0.0016 (–0.016, 0.019) 0.86
PCB-118b 1.16 (0.88, 1.44) 0.31 0.69 (–2.25, 3.63) 0.65 0.002 (–0.018, 0.022) 0.84
PCB-126c 1.06 (0.93, 1.21) 0.44 –3.26 (–4.92, –1.61) 0.0001 0.013 (0.002, 0.024) 0.022
PCB-138 1.46 (1.11, 1.93) 0.007 –1.24 (–4.54, 2.05) 0.46 0.008 (–0.014, 0.030) 0.46
PCB-153 1.65 (1.22, 2.25) 0.001 –0.10 (–3.72, 3.53) 0.96 0.011 (0.013, 0.035) 0.38
PCB-156b 1.95 (1.41, 2.71) 0.0001 1.41 (–2.41, 5.23) 0.47 0.001 (–0.025, 0.026) 0.95
PCB-157b 1.56 (1.17, 2.06) 0.002 –1.41 (–4.80, 1.97) 0.42 0.034 (0.011, 0.057) 0.003
PCB-169c 1.18 (0.87, 1.59) 0.28 –1.66 (–5.07, 1.75) 0.34 0.002 (–0.022, 0.026) 0.86
PCB-170 2.02 (1.43, 2.85) 0.0001 –1.93 (–6.04, 2.18) 0.36 0.022 (–0.006, 0.050) 0.13
PCB-180 1.86 (1.33, 2.61) 0.0001 –3.17 (–7.21, 0.87) 0.12 0.024 (–0.004, 0.051) 0.09
PCB-189b 1.15 (0.95, 1.39) 0.15 –0.75 (–3.11, 1.60) 0.53 0.007 (–0.009, 0.023) 0.41
PCB-194 1.14 (0.97, 1.33) 0.102 –10.30 (–12.13, –8.47) 0.0001 0.016 (0.002, 0.029) 0.020
PCB-206 1.66 (1.24, 2.23) 0.001 –9.64 (–13.09, –6.18) 0.0001 0.031 (0.007, 0.055) 0.012
PCB-209 1.51 (1.16, 1.95) 0.002 –13.24 (–16.30, –10.77) 0.0001 0.026 (0.004, 0.048) 0.018
OCDD 1.31 (1.06, 1.62) 0.01 2.97 (0.39, 5.55) 0.024 –0.017 (–0.019, 0.016) 0.85
HCB 1.20 (0.90, 1.60) 0.21 9.01 (5.49, 12.52) 0.0001 –0.001 (–0.024, 0.024) 0.99
TNC 1.33 (1.07, 1.66) 0.010 6.29 (3.67, 8.91) 0.0001 –0.002 (–0.020, 0.016) 0.82
DDE 1.02 (0.89, 1.17) 0.80 –2.53 (–4.21, –0.86) 0.003 –0.004 (–0.015, 0.007) 0.49
BDE-47 1.12 (0.93, 1.34) 0.24 2.42 (0.17, 4.67) 0.035 –0.008 (–0023, 0.0073) 0.31
Sum of PCBs (concentration) 1.03 (1.01, 1.05) 0.002 –0.40 (–0.65, –0.14) 0.002 0.001 (–0.00004, 0.0033) 0.057
Total TEQ 1.09 (0.90, 1.33) 0.34 –4.83 (–7.15, –2.52) 0.0001 0.021 (0.0052, 0.037) 0.009
TEQ for dioxin-like mono-ortho-
substituted PCBsb
1.67 (1.20, 2.32) 0.002 1.06 (–2.88, 5.02) 0.60 0.010 (–0.016, 0.037) 0.44
TEQ for dioxin-like coplanar, 
non-ortho-substituted PCBsc
1.09 (0.90, 1.32) 0.36 –4.50 (–6.79, –2.21) 0.0001 0.020 (0.0045, 0.037) 0.012
Penta-PCBs (concentration)  1.04 (0.98, 1.11) 0.12 –0.52 (–1.26, 0.21) 0.16 0.0029 (–0.0020, 0.0079) 0.25
Hexa-PCBs (concentration) 1.12 (1.05, 1.21) 0.001 –0.22 (–1.04, 0.60) 0.60 0.0034 (–0.0021, 0.0089) 0.23
Hepta-PCBs (concentration) 1.17 (1.06, 1.30) 0.0001 –0.68 (–1.91, 0.55) 0.28 0.0059 (–0.0024, 0.014) 0.16
Octa- to deca-PCBs (concentrations) 1.11 (1.03, 1.20) 0.007 –4.71 (–5.65, –3.77) 0.0001 0.0090 (0.0022, 0.015) 0.009
ap-Values are adjusted for sex, waist circumference, BMI, fasting blood glucose, SBP, DBP, HDL and LDL cholesterol, serum triglycerides, smoking, antihypertensive treatment, and 
statin use. bDioxin-like PCB (mono-ortho substituted). cDioxin-like PCB (coplanar, non-ortho substituted).Lind et al.
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2007, 2011a, 2011b; Rönn et al. 2011), it is 
unclear whether POPs might induce myo-
cardial infarction by altering risk factors or by a 
more direct action on the vascular wall.
Biological rationale. Development of ath-
erosclerosis is a complicated chain of events 
starting with accumulation of LDL choles-
terol in the subintimal space. After oxidation of 
LDL, immunocompetent cells such as mono-
cytes and T-cell lymphocytes are attracted to 
the site of lipid oxidation by activation of adhe-
sion molecules from the endothelium, and the 
chronic repair-of-injury process begins with the 
liberation of proinflammatory cytokines.
POPs may interfere with this process in 
several ways. For example, POPs have been 
associated with an increased blood pressure, 
with proatherogenic alterations in lipid metab-
olism, and with the development of diabe-
tes and obesity (Everett et al. 2008; Ha et al. 
2009; Lee et al. 2007, 2011b; Rönn et al. 
2011; Uemura et al. 2009). However, associa-
tions between several of the POPs and markers 
of atherosclerosis were evident despite adjust-
ment for classical CV risk factors, which sug-
gests that associations, if causal, might reflect 
direct effects of POPs on atherosclerosis. 
Moreover, POPs have been found to impair 
endothelium-dependent vasodilatation in mice 
(Kopf et al. 2008) and alter the expression of 
genes involved in DNA repair and cell cycling 
in vascular smooth muscle cells (Puga et al. 
2004). Several POPs activate the cytosolic aryl 
hydrocarbon receptor (AHR). For example, 
activation of the AHR by dioxin induces an 
oxidative stress response (Kopf et al. 2008; 
Park et al. 1996; Shertzer et al. 1998), which 
might contribute to atherosclerosis via the oxi-
dation of LDL, an early event in the forma-
tion of atherosclerotic plaques. Activation of 
the AHR also triggers up-regulation of genes 
such as cytochrome P450 1A1 (CYP1A1) 
and cyclooxygenase-2 (COX2), whose prod-
ucts metabolize arachidonic acid into vaso-
active eicosanoids known to be involved in 
the atherosclerotic process (Dalton et al. 
2001; Kraemer et al. 1996; Puga et al. 1997, 
2004). Cross talk between the AHR and sex-
  hormone receptors is a well-known occurrence 
(Ohtake et al. 2008), and it is also well known 
that estrogen and testosterone are important 
players in atherosclerosis (Bourghardt et al. 
2010; Kolovou et al. 2011). We have recently 
reported an association between circulating 
levels of the estrogen-receptor ligand bisphe-
nol A and atherosclerosis in the present study 
population (Lind and Lind 2011).
Other mechanisms may exist whereby 
POPs could influence several of the major 
stages in the atherosclerotic process. The asso-
ciation between TEQ and atherosclerosis in 
the present study, together with a previous 
experimental finding that tetrachloro  dibenzo-
p-dioxin increases the formation of plaques 
in apolipoprotein E knockout mice, a well-
known model of atherosclerosis formation 
(Dalton et al. 2001), supports the involvement 
of the AHR in atherosclerosis formation.
Different measurements of atherosclero-
sis. In the present study, we evaluated three 
markers that reflect different characteristics 
of the atherosclerotic process: plaque preva-
lence, IMT, and IM-GSM. All three measures 
are related to future CV events (Davidsson 
et al. 2010; O’Leary et al. 1999; Wohlin et al. 
2009), but IMT and IM-GSM are measured 
in the plaque-free part of the vascular wall and 
consequently represent processes that occur 
before overt plaques form. However, IMT 
and IM-GSM are poorly correlated with each 
other (R2 < 0.01), and although the major risk 
factors for IMT in the present cohort were 
SBP and smoking, the major risk factors for 
IM-GSM were lipids and markers of inflam-
mation and oxidative stress (Andersson et al. 
2009). This suggests that the two measures, 
IMT and IM-GSM, may reflect different 
aspects of atherosclerosis development that 
may be affected in different ways by POPs. 
Furthermore, although IMT and overt plaque 
formation were both associated with blood 
pressure and smoking in the study population, 
markers of oxidative stress and inflammation 
were more closely associated with plaque than 
with IMT (Andersson et al. 2009). This may 
explain why POPs could be more closely 
related with plaque prevalence than with IMT, 
i.e., because activation of the AHR could 
induce oxidative stress and inflammation (Park 
et al. 1996; Shertzer et al. 1998).
Carotid artery plaque. The presence of 
atherosclerotic plaques in the carotid arter-
ies is a known predictor of future CV events 
(O’Leary et al. 1999). Atherosclerosis in the 
carotid arteries is also predictive of plaques in 
the coronary circulation (Hulthe et al. 1997). 
Consequently, persons with carotid artery 
plaques are at increased risk for myocardial 
infarction. Furthermore, because persons with 
bilateral carotid plaques are at higher risk of 
future CV disorders compared with those with 
unilateral plaques (Davidsson et al. 2010), we 
used a graded response for carotid plaques (0, 
1, or 2 carotid arteries with plaques) rather 
than a binary outcome (plaque or no plaque) 
for our study participants.
Echogenicity of the intima-media com-
plex. The echogenicity of the intima-media 
complex is closely related to the echogenic-
ity of overt plaques (Lind et al. 2007) and 
has been shown to be a powerful predictor 
of future CV mortality (Wohlin et al. 2009). 
The echogenicity of overt plaques is related to 
the composition of the plaque (El-Barghouty 
et al. 1996), and it is therefore likely that the 
echogenicity of the intima-media complex 
is also a marker for the composition of the 
vascular wall.
In the present study, the highly chlori-
nated PCBs were associated with an echo-
lucent intima-media complex, a likely marker 
for a lipid-rich vascular wall, even after adjust-
ing for CV risk factors, including lipids. By 
contrast, HCB and TNC were associated 
with an echogenic intima-media complex, 
suggesting that these pesticides might affect 
vascular walls with compositions opposite to 
those affected by highly chlorinated POPs. 
In contrast to the findings for plaques, total 
TEQ was associated with IM-GSM, support-
ing an AHR-mediated effect of the PCBs on 
this outcome.
Intima-media thickness. IMT is a known 
predictor of CV events and is usually regarded 
as a marker of atherosclerosis (O’Leary et al. 
1999). Atherosclerosis is a disorder of the 
intima, but IMT also incorporates the media 
in the measurement and thus might distort 
the relationship with POP levels.
Non  linear relationships. In most cases, 
models of POPs categorized by quintiles sup-
ported linear relationships with athero  sclerosis. 
It has been argued that non  monotonic, low-
dose effects could be a characteristic feature 
of many POPs (Gregoraszczuk et al. 2008; 
Haase et al. 2009; Kim et al. 2010; Lee et al. 
2007), but the present study produced very 
little evidence to support this.
Adjustment for lipids. Traditionally, POP 
levels are normalized for lipids and given per 
gram lipid because these compounds are lipid 
soluble (Bernert et al. 2007). However, this 
normalization may not be appropriate when 
dealing with CV diseases because POP expo-
sure has been shown to alter lipid levels in 
both human and animal studies (Bell et al. 
1994; Goncharov et al. 2008; Kanagawa et al. 
2008; Kratz 2005; Lind et al. 2004). We 
therefore chose to use wet-weight levels for the 
POPs but adjusted for lipids (together with 
the multiple risk factors) in the second model. 
It has also been argued that lipid normal-
ization tends to overadjust for the effects of 
lipids and that adjusting the statistical models 
is more appropriate (Gaskins and Schisterman 
2009). This lipid adjustment, however, only 
marginally changed the results in the pres-
ent study. Furthermore, essentially the same 
results as presented above were obtained when 
we used lipid-normalized POP levels in the 
analysis (data not shown).
Limitations of the study. The cross-
sectional study population was limited to 
Caucasians 70 years of age, which means that 
caution should be taken about generalizing to 
other ethnic and age groups.
The present study had a moderate par-
ticipation rate. However, an analysis of non-
participants showed the present sample to be 
fairly representative of the total population 
regarding most CV disorders and drug intake 
(Lind et al. 2005).POPs and carotid atherosclerosis
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Conclusions
Circulating levels of PCBs were associated 
with atherosclerotic plaques and the echo-
genicity of the intima-media complex inde-
pendent of CV risk factors, including lipids. 
This suggests an effect of POPs on the risk of 
myocardial infarction that should be investi-
gated in prospective studies.
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